Baxter International's revenue has shrunk by 0.7% a year over the last 5 years; the median of the Health Care sector is +8.5%. The last fiscal year ended with a net loss (net margin −8.5%, sector median 13.9%). The 52-week high is 18.2% away (close of Nov 20, 2026).
Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself.Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself.Academy: 200-day line · RSI
About the company
Baxter International is a US medical technology company. It makes IV solutions and infusion pumps, hospital beds, monitoring devices and surgical products. The kidney dialysis business was sold as Vantive. Customers are mainly hospitals worldwide. As of Oct 11, 2026
As of Oct 11, 2026Fact sheet (from the annual report)Medical instruments · Deerfield, USAfull fact sheet
Baxter offers sterile IV solutions, infusion systems, parenteral nutrition therapies, inhaled anesthetics and generic injectable drugs. It also offers products for stopping bleeding in surgery, surgical equipment, connected bed systems, patient monitoring and respiratory devices. Its reportable segments are Medical Products & Therapies, Healthcare Systems & Technologies and Pharmaceuticals. The products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, dialysis centers and in patients’ homes under medical supervision. In January 2025 Baxter completed the sale of its Kidney Care business to Carlyle, and in September 2023 that of its BioPharma Solutions business. Sales run through its own field sales force, independent distributors and wholesalers.
This symbol belongs to the extended universe: we load daily candles only and show metrics, fundamentals and an overview – chart methods and Elliott analysis are not available for it.
Calculated automatically by fixed rules – not investment advice, check for yourself. How we analyze
Price performance at a glance
Last 30 trading days
Today−0.0%
7 days−1.7%
30 days+2.8%
1 year+45.7%
Day range (last trading day)
−2.1%Price at 43% of the range+2.8%
52-week range
−38.0%Price at 68% of the range+18.2%
Distance from the all-time high
−73.3%
Our own calculation from the exchange’s daily candles, as of Nov 20, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.
Chart analysis: trend by timeframe
Trend by timeframeFor each timeframe (week, day, 4 hours): up when the close is above the SMA 200, the EMA 20 above the EMA 50 and the structure shows higher highs and lows. Down the other way round, otherwise mixed. No score, no forecast.Example: Week up, day up, 4 hours mixed → not aligned.More in the Academy: Lesson trend and market structure
1Wweekly candles↔ mixed
Close below the SMA 200
EMA 20 above the EMA 50
Highs and lows mixed
Price above the EMA 20 · above the EMA 50
Week to Nov 20, 2026
1Ddaily candles↔ mixed
Close above the SMA 200
EMA 20 above the EMA 50
Highs and lows mixed
Price below the EMA 20 · above the EMA 50
Daily candle of Nov 20, 2026
4H4-hour candles– not available
No value on 4 hours (too few or no checked 4-hour candles).
Rule per timeframe: up = close above the SMA 200, EMA 20 above the EMA 50 and higher highs and lows; down = everything the other way round; otherwise mixed. Completed candles only, no overall score, no forecast. In the screener: all three up →
What does the daily chart show right now – line by line, without an overall verdict?
Technicals in plain words
Technicals in plain wordsFour lines on the daily chart – trend, momentum, volume, volatility –, each with its metric and threshold. We do not add the lines up or give a grade; they describe the price history so far.Example: RSI 64 → between 30 and 70, neither overbought nor oversold.More in the Academy: Lesson reading the RSI
Over the last 3 months it ran stronger than the S&P 500 and weaker than the median of the sector “Health Care”.
vs. S&P 500 · 3 monthsRelative strengthA stock’s price change minus that of the benchmark over the same period, in percentage points: against the S&P 500 (ETF SPY) or the median of its sector, over 3 or 6 months. Above 0 it ran stronger, below 0 weaker – this describes the past.Example: Stock +12%, S&P 500 +5% in 3 months → +7 percentage points, ran stronger.More in the Academy: Lesson relative strength
stronger
vs. S&P 500 · 6 monthsRelative strengthA stock’s price change minus that of the benchmark over the same period, in percentage points: against the S&P 500 (ETF SPY) or the median of its sector, over 3 or 6 months. Above 0 it ran stronger, below 0 weaker – this describes the past.Example: Stock +12%, S&P 500 +5% in 3 months → +7 percentage points, ran stronger.More in the Academy: Lesson relative strength
stronger
vs. sector · 3 monthsRelative strengthA stock’s price change minus that of the benchmark over the same period, in percentage points: against the S&P 500 (ETF SPY) or the median of its sector, over 3 or 6 months. Above 0 it ran stronger, below 0 weaker – this describes the past.Example: Stock +12%, S&P 500 +5% in 3 months → +7 percentage points, ran stronger.More in the Academy: Lesson relative strength
weaker
Trendabove SMA 200Price above the 200-day line – above it the long-term trend counts as up; ADX below 20 – hardly any trend.
MomentumneutralRSI between 30 and 70 – neither overbought nor oversold; MACD line fell below its signal line in the last 5 trading days.
Volumenot elevatedVolume on the last trading day below 1.5 times the average of up to 50 trading days before – not elevated.
VolatilitynormalTypical daily range (ATR 14) between 2 and 4% of the price – normal.
The figures behind it – distance to the line, RSI, volume, volatility and relative strength in percentage points – are visible with a free account.Sign up free
More depth
How we read the lines
Each line stands on its own – we do not add them up and give no grade.
Trend: the 200-day line is the average of the last 200 closing prices. The ADX (14) measures how pronounced a trend is, not its direction: below 20 hardly any trend, above 25 pronounced.
Momentum: the RSI (14) lies between 0 and 100; below 30 it counts as oversold, above 70 as overbought. The MACD (12/26) compares two averages, the signal line (9) smooths it.
Volume: shares traded on the last trading day divided by the average of up to 50 trading days before; from 1.5x elevated, from 2x unusually high, from 3x very high.
Volatility: typical daily range (ATR 14) as a percentage of the price; below 2% calm, 2 to 4% normal, above 4% high. Squeeze = Bollinger Bands as narrow as on at most a fifth of the last 120 trading days.
Relative strength: the stock’s price change minus that of the benchmark over the same period (3 months = 91 days, 6 months = 182 days), in percentage points, from completed daily candles. Benchmark: the S&P 500 (ETF SPY) or the median of the stocks of the same sector in our selection (at least 5 others with a candle on the same day). Dividends are not included.
Against the sector median over 6 months: ran stronger.
All figures describe the price history so far – they do not say what happens next.
As of: daily candle of Nov 20, 2026 · from our daily candles
How did this asset do in each calendar month over the last 10 years?
Seasonality
SeasonalityHow an asset did in each calendar month over the last 10 years: monthly return from the last trading day of the previous month to the last one of the month, without dividends, completed months only. Past performance, not a forecast.Example: Example: November higher in 7 of 10 years → describes past years, not the next November.More in the Academy: Lesson seasonality
In November, the stock closed higher in 6 of 10 years – the S&P 500 in 9 of 10.
Years higher in NovemberSeasonalityHow an asset did in each calendar month over the last 10 years: monthly return from the last trading day of the previous month to the last one of the month, without dividends, completed months only. Past performance, not a forecast.Example: Example: November higher in 7 of 10 years → describes past years, not the next November.More in the Academy: Lesson seasonality
6 of 10
2016 to 2025
S&P 500 in November
9 of 10
years higher, same years as above (ETF SPY)
Months mostly higher
5 of 12
Calendar months that closed higher in more than half of the years
You can see the median and range per month in percent with a free account.Sign up free
7/10Jan
6/10Feb
5/10Mar
6/10Apr
5/10May
5/10Jun
4/10Jul
6/10Aug
4/10Sep
2/10Oct
6/10Nov
5/10Dec
January: higher in 7 of 10 years
February: higher in 6 of 10 years
March: higher in 5 of 10 years
April: higher in 6 of 10 years
May: higher in 5 of 10 years
June: higher in 5 of 10 years
July: higher in 4 of 10 years
August: higher in 6 of 10 years
September: higher in 4 of 10 years
October: higher in 2 of 10 years
November (current month): higher in 6 of 10 years
December: higher in 5 of 10 years
Past performance, not a forecast · Bar = share of years higher, line = half · Price return without dividendsMore depth
How we calculate
Monthly return = closing price on the last trading day of the month ÷ closing price on the last trading day of the previous month − 1. Price return without dividends.
Only completed months count, never the current one. If the candle of the last trading day is missing, the month does not count.
For each calendar month the last 10 years in which it has ended; from 8 years with a value we show the median, years higher and the range. “Higher” means: return above 0.0%.
Past performance, not a forecast: the figures describe earlier years and do not tell how the next month will go.
By calendar month (● = current month)
Month
Years higher
January
7 of 10
February
6 of 10
March
5 of 10
April
6 of 10
May
5 of 10
June
5 of 10
July
4 of 10
August
6 of 10
September
4 of 10
October
2 of 10
November ●
6 of 10
December
5 of 10
Through October 2026 (last completed month) · from our daily candles
Fundamental analysis
SEC filing (10-K, 10-Q)Required reports of listed companies to the US Securities and Exchange Commission (SEC): 10-K is the annual report, 10-Q the quarterly report, 20-F the annual report of foreign companies. We show the figures of the first filing.Example: 10-K for the fiscal year ending Sep 27, 2025, filed on Oct 31, 2025.More in the Academy: Lesson revenue, profit and margin
Baxter International · Sector Health Care · amounts in USD
Source: SEC filings, As of Feb 12, 2026.
Investor typeInvestor type (“lens”)You choose which style comes first: dividends, valuation, growth, quality or trading. Screener and stock page then show suggestions and “For you first”, with an account also matching columns and order. The lens unlocks nothing and changes no matches.Example: Lens “Dividends” → on the stock page first the streak without a cut, growth and cover of the dividend.More in the Academy: Guide fundamental analysis
For you firstDividend
The dividend per share was cut in fiscal year 2025 compared with the year before; free cash flow per share covers it 1.2x.
Four angles on the annual figures. Each check counts how many disclosed criteria are met – criteria without data do not count. The bars show where the company ranks on each figure among the stocks we cover and within its sector.
✗not met: Profit in each of the last 5 fiscal years2 of 5
✓met: Free cash flow positive in each of the last 3 fiscal years3 of 3
✓met: Equity ratio above 30%30.6%
Gross margin
30.1%Fiscal year 2025
All22weak
Rank 22 of 100: higher than 22% of 370 peers (All). weak.
Sector11weak
Rank 11 of 100: higher than 11% of 49 peers (Sector). weak.
Median Health Care: 61.8%
Share of revenue left after the direct cost of the products sold.
Operating margin
−2.7%Fiscal year 2025
All13weak
Rank 13 of 100: higher than 13% of 470 peers (All). weak.
Sector10weak
Rank 10 of 100: higher than 10% of 54 peers (Sector). weak.
Median Health Care: 17.0%
Operating income divided by revenue: what the core business earns before interest and taxes.
Net margin
−8.5%Fiscal year 2025
All8weak
Rank 8 of 100: higher than 8% of 584 peers (All). weak.
Sector7weak
Rank 7 of 100: higher than 7% of 63 peers (Sector). weak.
Median Health Care: 12.9%
Profit after all costs, interest and taxes divided by revenue.
Return on equity
−15.6%Fiscal year 2025
All7weak
Rank 7 of 100: higher than 7% of 544 peers (All). weak.
Sector8weak
Rank 8 of 100: higher than 8% of 54 peers (Sector). weak.
Median Health Care: 12.8%
Net income divided by equity at fiscal year end.
Return on assets
−4.8%Fiscal year 2025 (total assets at year end)
All8weak
Rank 8 of 100: higher than 8% of 594 peers (All). weak.
Sector9weak
Rank 9 of 100: higher than 9% of 63 peers (Sector). weak.
Median Health Care: 6.6%
Net income divided by total assets at fiscal year end.
Equity ratio
30.6%Fiscal year 2025
All40medium
Rank 40 of 100: higher than 40% of 595 peers (All). medium.
Sector31weak
Rank 31 of 100: higher than 31% of 63 peers (Sector). weak.
Median Health Care: 44.2%
Equity as a share of total assets. Usually low for banks.
Free cash flow margin
3.0%Fiscal year 2025
All23weak
Rank 23 of 100: higher than 23% of 465 peers (All). weak.
Sector20weak
Rank 20 of 100: higher than 20% of 61 peers (Sector). weak.
Median Health Care: 14.5%
Free cash flow divided by revenue.
Free cash flow
332.0M USDFiscal year 2025
Operating cash flow minus capital expenditure on property and equipment.
Growth 1 of 7 met
✗not met: Over 3 years, revenue grew by more than 5% per year−9.4%
✗not met: Over 5 years, revenue grew by more than 5% per year−0.7%
✗not met: Over 10 years, revenue grew by more than 5% per year+1.2%
✗not met: Over 3 years, EPS grew by more than 5% per yearno earnings per share in the last fiscal year
✗not met: Over 5 years, EPS grew by more than 5% per yearno earnings per share in the last fiscal year
✗not met: Revenue rose in at least 4 of the last 5 fiscal years3 of 5
✓met: Revenue rose in the last fiscal year+5.7%
Revenue growth 3 years
−9.4%per year
All5weak
Rank 5 of 100: higher than 5% of 578 peers (All). weak.
Sector6weak
Rank 6 of 100: higher than 6% of 62 peers (Sector). weak.
Median Health Care: +5.1%
Average growth per year over 3 fiscal years.
Revenue growth 5 years
−0.7%per year
All6weak
Rank 6 of 100: higher than 6% of 549 peers (All). weak.
Sector4weak
Rank 4 of 100: higher than 4% of 60 peers (Sector). weak.
Median Health Care: +7.8%
Average growth per year over 5 fiscal years.
Revenue growth 10 years
+1.2%per year
All12weak
Rank 12 of 100: higher than 12% of 412 peers (All). weak.
Sector5weak
Rank 5 of 100: higher than 5% of 50 peers (Sector). weak.
Median Health Care: +9.3%
Average growth per year over 10 fiscal years.
Dividend 4 of 7 met
✓met: Pays a dividend0.52 USD
✗not met: Payout ratio at most 60% of earningsdespite a loss
✓met: Dividend paid in each of the last 5 fiscal years5 of 5
✗not met: Dividend per share never lowered in the last 5 fiscal yearsDividend per share as filed with the SEC, including special dividends; a one-off higher prior year does not count as a cut.2 times
✗not met: Dividend per share higher than 5 years ago−11.4%
✓met: Free cash flow per share covers the dividend1.2x
✓met: Dividends paid over the last 5 years covered by free cash flow67% of free cash flow
Dividend growth 5 years
−11.4%per year
All1weak
Rank 1 of 100: higher than 1% of 321 peers (All). weak.
Sector2weak
Rank 2 of 100: higher than 2% of 31 peers (Sector). weak.
Median Health Care: +6.6%
Growth of the dividend per share per year.
Free cash flow coverage
1.2xFiscal year 2025
Free cash flow per share divided by dividend per share. From 1x the dividend is covered.
Financial strength 4 of 6 met
✗not met: Piotroski F-Score at least 7 of 95 of 9
✗not met: Long-term debt no higher than equity1.55
✓met: Current assets cover current liabilities2.31
✓met: Positive equity6.1B USD
✓met: In 5 years, share count up by at most 5%−0.8%
✓met: Free cash flow positive in the last fiscal year332.0M USD
Piotroski F-Score
5 of 9Fiscal year 2025
All22weak
Rank 22 of 100: higher than 22% of 310 peers (All). weak.
Sector17weak
Rank 17 of 100: higher than 17% of 47 peers (Sector). weak.
Median Health Care: 6.0 of 9
Nine yes/no tests on profit, cash flow, debt, liquidity and efficiency compared with the prior year.
Debt / equity
1.55at fiscal year end
All18weak
Rank 18 of 100: lower than 18% of 486 peers (All). weak.
Sector11weak
Rank 11 of 100: lower than 11% of 50 peers (Sector). weak.
Median Health Care: 0.66
Long-term financial debt divided by equity.
Liquidity (current ratio)
2.31at fiscal year end
All79strong
Rank 79 of 100: higher than 79% of 513 peers (All). strong.
Sector75strong
Rank 75 of 100: higher than 75% of 63 peers (Sector). strong.
Median Health Care: 1.58
Current assets divided by current liabilities.
Change in share count
−0.8%in 5 years
All42medium
Rank 42 of 100: lower than 42% of 507 peers (All). medium.
Sector33medium
Rank 33 of 100: lower than 33% of 59 peers (Sector). medium.
Median Health Care: −4.3%
Change in diluted share count. Negative = share buybacks, positive = new shares.
The 9 criteria of the Piotroski F-Score
✗not met: Profit in the last fiscal year (positive return on assets)
✓met: Positive operating cash flow
✗not met: Return on assets higher than the prior year
✓met: Operating cash flow higher than net income
✓met: Long-term debt relative to total assets fell
✓met: Liquidity (current assets / current liabilities) rose
✗not met: No additional shares (diluted share count did not rise)
✗not met: Gross margin higher than the prior year
✓met: Revenue relative to total assets higher than the prior year
Last fiscal year compared with the one before. Returns and revenue per total assets use total assets at the start of the year; leverage = long-term financial debt divided by total assets at year end; new shares via the average diluted share count.
Price-based criteria (P/E, dividend yield) are shown to signed-in users.
Computed automatically from SEC annual reports – not investment advice. Describes the reported figures; points are not a rating of the stock. Rank 0–100 against the 239 stocks we cover and against the sector (from 5 peers); the stronger side is always on the right.
In short
Light red: Revenue shrank over 5 years (−0.7% per year).
Light red: Loss in the last fiscal year.
Light red: Debt much higher than usual in the sector.
Light red: Profit in 7 of 10 fiscal years.
Light red: Dividend higher than earnings.
Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.
RevenueNet incomeNet margin (below)in USD
05B10B15B20B
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Revenue 10.2B USD · Net income 5.0B USD · Net margin 48.9%
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Revenue 10.6B USD · Net income 717.0M USD · Net margin 6.8%
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Revenue 11.1B USD · Net income 1.6B USD · Net margin 14.6%
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Revenue 11.4B USD · Net income 1.0B USD · Net margin 8.8%
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Revenue 11.7B USD · Net income 1.1B USD · Net margin 9.4%
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Revenue 12.8B USD · Net income 1.3B USD · Net margin 10.0%
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Revenue 15.1B USD · Net income −2.4B USD · Net margin −16.1%
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Revenue 14.8B USD · Net income 2.7B USD · Net margin 17.9%
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Revenue 10.6B USD · Net income −649.0M USD · Net margin −6.1%
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 11.2B USD · Net income −957.0M USD · Net margin −8.5%
Margin
49%6.8%15%8.8%9.4%10%−16%18%−6.1%−8.5%
RevenueNet incomeNet margin (below)in USD
−2B02B4B
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Revenue 3.9B USD · Net income 245.0M USD · Net margin 6.3%
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Revenue 3.6B USD · Net income 37.0M USD · Net margin 1.0%
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Revenue 3.8B USD · Net income −314.0M USD · Net margin −8.2%
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Revenue 2.7B USD · Net income 140.0M USD · Net margin 5.2%
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Revenue 2.8B USD · Net income −512.0M USD · Net margin −18.6%
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Revenue 2.6B USD · Net income 126.0M USD · Net margin 4.8%
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Revenue 2.8B USD · Net income 91.0M USD · Net margin 3.2%
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Revenue 2.8B USD · Net income −46.0M USD · Net margin −1.6%
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Revenue 3.0B USD · Net income −1.1B USD · Net margin −37.9% · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/26Quarter Q1/26 (Jan 1, 2026 – Mar 31, 2026): Revenue 2.7B USD · Net income −15.0M USD · Net margin −0.6%
Q2/26Quarter Q2/26 (Apr 1, 2026 – Jun 30, 2026): Revenue 3.0B USD · Net income 126.0M USD · Net margin 4.3%
Q3/26Quarter Q3/26 (Jul 1, 2026 – Sep 30, 2026): Revenue 3.0B USD · Net income 294.0M USD · Net margin 9.9%
Dividend per sharePayout ratio (below)USD per share
00.501.001.50
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Dividend per share 0.51 USD · Payout ratio 5.6%
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Dividend per share 0.61 USD · Payout ratio 47.3%
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Dividend per share 0.73 USD · Payout ratio 24.6%
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Dividend per share 0.85 USD · Payout ratio 44.0%
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Dividend per share 0.96 USD · Payout ratio 44.8%
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Dividend per share 1.09 USD · Payout ratio 42.9%
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Dividend per share 1.15 USD · Payout ratio not available
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Dividend per share 1.16 USD · Payout ratio 22.1%
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Dividend per share 1.04 USD · Payout ratio not available
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Dividend per share 0.52 USD · Payout ratio not available
Ratio
5.6%47%25%44%45%43%22%
Dividend per sharePayout ratio (below)USD per share
00.100.200.30
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Dividend per share 0.29 USD · Payout ratio 60.4%
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Dividend per share 0.29 USD · Payout ratio 414.3%
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Dividend per share 0.29 USD · Payout ratio not available
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Dividend per share 0.29 USD · Payout ratio 107.4%
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Dividend per share 0.17 USD · Payout ratio not available
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Dividend per share 0.17 USD · Payout ratio 68.0%
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Dividend per share 0.17 USD · Payout ratio 94.4%
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Dividend per share 0.17 USD · Payout ratio not available
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Dividend per share 0.01 USD · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/26Quarter Q1/26 (Jan 1, 2026 – Mar 31, 2026): Dividend per share 0.01 USD · Payout ratio not available
Q2/26Quarter Q2/26 (Apr 1, 2026 – Jun 30, 2026): Dividend per share 0.01 USD · Payout ratio 4.2%
Q3/26Quarter Q3/26 (Jul 1, 2026 – Sep 30, 2026): Dividend per share 0.01 USD · Payout ratio 1.8%
Ratio
60%414%107%68%94%4.2%1.8%
Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 11.2B USD · Net income −957.0M USD · Net margin −8.5%
How has it gone since the last annual report?
Trailing 12 months and quarters
Trailing 12 monthsFigures for the latest twelve months: fiscal year plus the months since it ended minus the same months a year earlier, each from the first SEC filing. More current than the fiscal year, but not audited. P/E, PEG and the checks still use the fiscal year.Example: Fiscal year $400M, 9 months after it $330M, same 9 months a year earlier $300M → 400 + 330 − 300 = $430M.More in the Academy: Lesson trailing twelve months
Revenue in the quarter to Sep 2026 +5.0% vs. the same quarter a year earlier; grown for at least 13 quarters in a row.
Revenue 12 months vs. prior 12Trailing 12 monthsFigures for the latest twelve months: fiscal year plus the months since it ended minus the same months a year earlier, each from the first SEC filing. More current than the fiscal year, but not audited. P/E, PEG and the checks still use the fiscal year.Example: Fiscal year $400M, 9 months after it $330M, same 9 months a year earlier $300M → 400 + 330 − 300 = $430M.More in the Academy: Lesson trailing twelve months
Free cash flow margin 12 monthsFree cash flowCash from operations minus investment in property, plant and equipment. It shows how much money is left over – for repaying debt, dividends or share repurchases.Example: Operating cash flow 120 million euros, investments 45 million euros → free cash flow 75 million euros.More in the Academy: Guide fundamental analysis
–
Cash flow or capital expenditure not reported
More depth
Calculation of the 12 months to Sep 30, 2026
Revenue: fiscal year to Dec 31, 2025 11.2B USD + year to date to Sep 30, 2026 8.6B USD − same period a year earlier to Sep 30, 2025 8.3B USD = 11.6B USD
Net income: fiscal year to Dec 31, 2025 −957.0M USD + year to date to Sep 30, 2026 405.0M USD − same period a year earlier to Sep 30, 2025 171.0M USD = −723.0M USD
Operating cash flow: fiscal year to Dec 31, 2025 845.0M USD + year to date to Sep 30, 2026 1.1B USD − same period a year earlier to Sep 30, 2025 261.0M USD = 1.6B USD
By quarter (latest first, amounts in USD)
Quarter
Revenue
vs. year ago
Net income
Margin
Jul–Sep 26
3.0B
+5.0%
294.0M
9.9%
Apr–Jun 26
3.0B
+5.3%
126.0M
4.3%
Jan–Mar 26
2.7B
+2.9%
−15.0M
−0.6%
Oct–Dec 25*
3.0B
+8.0%
−1.1B
−37.9%
Jul–Sep 25
2.8B
+5.0%
−46.0M
−1.6%
Apr–Jun 25²
2.8B
+4.3%
91.0M
3.2%
Jan–Mar 25²
2.6B
+5.4%
126.0M
4.8%
Oct–Dec 24²
2.8B
+0.9%
−512.0M
−18.6%
Trailing 12 months = last fiscal year + the period since the start of the current fiscal year − the same period a year earlier, each from the first filing. P/E, PEG and the quality checks still use the last fiscal year.
Each quarter is compared with the same quarter a year earlier.
* derived: fiscal year minus the first 9 months.
² Year-ago quarter restated after a spin-off or divestiture – compared with the restated figure from the same report.
As of: 12 months to Sep 30, 2026, filed on Oct 29, 2026 · Source: SEC filings (10-Q, 10-K)
Does the profit arrive as cash?
Earnings quality
There was no profit in fiscal year 2025; operating income does not cover interest.
Cash flow ÷ profitCash flow ÷ profitOperating cash flow divided by group profit. From 1.0, at least as much cash came in as profit was reported; below that, profit may sit in receivables or inventories, and non-cash gains or one-off payments also push the ratio down. Depreciation and stock-based pay lift it.Example: Operating cash flow €120m, group profit €100m → 1.20x.More in the Academy: Lesson earnings quality
–
no profit in fiscal year 2025
Interest coverageInterest coverageOperating income divided by interest expense: how many times the core business earns its interest. From 5x we count interest as well covered, below 2x as thinly covered.Example: Operating income €50m, interest expense €5m → 10.0x.More in the Academy: Lesson earnings quality
negative
25
operating income negative · 3 years: 0.1x
Tax rateTax rateIncome taxes divided by profit before tax, in percent. If the SEC data lack it, we approximate it as group profit plus taxes; minority interests, discontinued operations, one-off items and tax credits can shift the rate.Example: Taxes €21m, net income €79m → 21 : 100 = 21%.More in the Academy: Lesson earnings quality
–
no profit before tax
More depth
Calculation for fiscal year 2025
Operating cash flow 845.0M USD ÷ Net income −957.0M USD = no ratio (no profit)
Taxes 395.0M USD ÷ profit before tax −505.0M USD = no rate (no profit before tax)
By fiscal year
FY
Cash flow ÷ profit
Interest coverage
Tax rate
2025
–
negative
–
2024
–
0.0x
–
2023
0.65x
0.8x
–
2022
–
negative
–
2021
1.72x
8.3x
12.3%
How it is rated: cash flow ÷ profit from 1.0 “backed by cash”, below 0.8 “profit well above the cash coming in”; interest coverage from 5 “well covered”, below 2 “thinly covered”. The tax rate is only shown.
Cash flow ÷ profit uses group profit incl. minority interests, because cash flow also covers the whole group. Profit before tax as reported to the SEC, otherwise approximated. “3 years” = sums of the last three fiscal years – only if every year is reported and the figures have the same origin; for cash flow only with a profit in every year.
As of fiscal year 2025 · Source: SEC filings
How even were the last years?
Consistency
In 10 fiscal years 3 loss years and 2 years with lower revenue.
Loss yearsLoss yearsFiscal years that ended with a loss on the bottom line (net income below zero). Few loss years over a long period show how evenly a company has earned so far – they say nothing about the future.Example: Loss only in fiscal year 2020 → 1 of 10.More in the Academy: Lesson revenue, profit and margin
3 of 10
net income below zero
Years with lower revenueYear with lower revenueA fiscal year in which revenue was lower than in the prior year. Only years for which the prior year’s revenue is also reported are counted.Example: Revenue 100 → €96m → one year with lower revenue.More in the Academy: Lesson revenue, profit and margin
2 of 10
revenue below the prior year
Net margin rangeNet margin rangeHighest minus lowest net margin of the fiscal years shown, in percentage points. A small range means the share of profit in revenue stayed similar over the years.Example: Net margins between 18.2% and 26.4% → range 8.2 percentage points.More in the Academy: Lesson revenue, profit and margin
65.0 percentage points
from −16.1% to 48.9%
▾▾20162025Net margin by fiscal year · ▾ revenue below the prior yearMore depth
By fiscal year
FY
Revenue vs. prior year
Net margin
2025
+5.7%
−8.5%
2024
−28.2%
−6.1%
2023
−2.0%
17.9%
2022
+18.2%
−16.1%
2021
+9.5%
10.0%
2020
+2.7%
9.4%
2019
+2.1%
8.8%
2018
+5.4%
14.6%
2017
+3.9%
6.8%
2016
+2.0%
48.9%
Loss year: net income below zero. Lower revenue: revenue below the prior year. Range: highest minus lowest net margin; margins beyond ±200% do not count. No score – only the reported figures.
As of fiscal years 2016–2025 · Source: SEC filings
Figures over time
Where the money of a fiscal year goes and how margins, returns, balance sheet, cash flow and share count developed over up to 10 years. Each chart has one sentence saying what the trend shows.
Money flow in fiscal year 2025
Of 100 USD of revenue, 30.1 USD gross profit remained.
2016Fiscal year 2016: Operating cash flow 1.7B USD · Capital expenditure 719.0M USD · Free cash flow 935.0M USD
2017Fiscal year 2017: Operating cash flow 1.8B USD · Capital expenditure 634.0M USD · Free cash flow 1.2B USD
2018Fiscal year 2018: Operating cash flow 2.1B USD · Capital expenditure 681.0M USD · Free cash flow 1.4B USD
2019Fiscal year 2019: Operating cash flow 2.1B USD · Capital expenditure 696.0M USD · Free cash flow 1.4B USD
2020Fiscal year 2020: Operating cash flow 1.9B USD · Capital expenditure 709.0M USD · Free cash flow 1.2B USD
2021Fiscal year 2021: Operating cash flow 2.2B USD · Capital expenditure 743.0M USD · Free cash flow 1.5B USD
2022Fiscal year 2022: Operating cash flow 1.2B USD · Capital expenditure 679.0M USD · Free cash flow 532.0M USD
2023Fiscal year 2023: Operating cash flow 1.7B USD · Capital expenditure 692.0M USD · Free cash flow 1.0B USD
2024Fiscal year 2024: Operating cash flow 1.0B USD · Capital expenditure 446.0M USD · Free cash flow 573.0M USD
2025Fiscal year 2025: Operating cash flow 845.0M USD · Capital expenditure 513.0M USD · Free cash flow 332.0M USD
Share count
The share count stayed roughly the same in 5 years.
Diluted share count
0200M400M600M
2016Fiscal year 2016: Diluted share count 551.0M
2017Fiscal year 2017: Diluted share count 555.0M
2018Fiscal year 2018: Diluted share count 546.0M
2019Fiscal year 2019: Diluted share count 519.0M
2020Fiscal year 2020: Diluted share count 517.0M
2021Fiscal year 2021: Diluted share count 508.0M
2022Fiscal year 2022: Diluted share count 504.0M
2023Fiscal year 2023: Diluted share count 506.0M
2024Fiscal year 2024: Diluted share count 510.0M
2025Fiscal year 2025: Diluted share count 513.0M
From annual reports filed with the SEC (10-K, 20-F, 40-F) as first reported, share count adjusted for splits; obvious filing errors (e.g. wrong unit, outliers against both neighbouring years) are hidden. Describes the reported figures – not investment advice.
Metrics chart
Metrics chartUp to three metrics stacked, each with its own axis, over the same fiscal years. Optionally a second stock (dashed or hatched) and today’s sector median as a mark in the latest year – we do not have earlier medians.Example: Revenue rises, net margin falls, share count falls → more business, less profit per unit of revenue, fewer shares (mostly through buybacks).More in the Academy: Guide fundamental analysis
Up to three metrics stacked over the same fiscal years – so you see at a glance whether they rise together or drift apart. Point at a year to read it in every panel.
Dividend per share
The dividend per share fell in 5 years from 0.96 USD to 0.52 USD.
BAXUSD per share
00.501.001.50
2016Fiscal year 2016: BAX 0.51 USD
2017Fiscal year 2017: BAX 0.61 USD
2018Fiscal year 2018: BAX 0.73 USD
2019Fiscal year 2019: BAX 0.85 USD
2020Fiscal year 2020: BAX 0.96 USD
2021Fiscal year 2021: BAX 1.09 USD
2022Fiscal year 2022: BAX 1.15 USD
2023Fiscal year 2023: BAX 1.16 USD
2024Fiscal year 2024: BAX 1.04 USD
2025Fiscal year 2025: BAX 0.52 USD
Payout ratio (earnings)
The payout ratio fell in 5 years from 24.6% to 22.1%.
BAX
0%20%40%60%
2016Fiscal year 2016: BAX 5.6%
2017Fiscal year 2017: BAX 47.3%
2018Fiscal year 2018: BAX 24.6%
2019Fiscal year 2019: BAX 44.0%
2020Fiscal year 2020: BAX 44.8%
2021Fiscal year 2021: BAX 42.9%
2022Fiscal year 2022: BAX not available
2023Fiscal year 2023: BAX 22.1%
2024Fiscal year 2024: BAX not available
2025Fiscal year 2025: BAX not available
Payout ratio (free cash flow)
The payout ratio (free cash flow) rose in 5 years from 40.8% to 104.8%.
BAX
0%50%100%150%
2016Fiscal year 2016: BAX 28.7%
2017Fiscal year 2017: BAX 26.2%
2018Fiscal year 2018: BAX 26.6%
2019Fiscal year 2019: BAX 30.0%
2020Fiscal year 2020: BAX 40.8%
2021Fiscal year 2021: BAX 35.8%
2022Fiscal year 2022: BAX 107.7%
2023Fiscal year 2023: BAX 56.7%
2024Fiscal year 2024: BAX 103.0%
2025Fiscal year 2025: BAX 104.8%
Source: SEC filings, fiscal years up to Dec 31, 2025. The same figures as in the sections of this page, per fiscal year as first reported. Describes the reported figures – not investment advice.
How reliable is the dividend?
Dividend at a glance
The dividend per share was cut in fiscal year 2025 compared with the year before; free cash flow per share covers it 1.2x.
Years without a cutYears without a dividend cutHow many fiscal years in a row up to the latest the dividend per share has not fallen, adjusted for stock splits. Only 1% less than the year before counts as a cut, a special dividend in the prior year does not. If the run reaches the start of our data, “at least” is shown.Example: Dividend 1.10 – 0.90 – 0.95 – 1.00 – 1.05 € → 3 years without a cut since the cut.More in the Academy: Lesson debt, dividends and growth
0
cut in fiscal year 2025
Growth per year (5 yrs)Dividend growthHow much the dividend per share has risen on average per year, calculated over 5 fiscal years. Only for companies that paid a dividend in the last fiscal year.Example: Dividend €1.00 five years ago, €1.40 today → 7.0% per year.More in the Academy: Lesson debt, dividends and growth
−11.4%
dividend per share, average per year
Coverage by free cash flowDividend coverage by free cash flowFree cash flow per share divided by dividend per share. From 1x, the cash freely available in a year covers the dividend; below that, the company pays out more than is left over. We do not calculate it for the financial sector.Example: Free cash flow €3.00 per share, dividend €2.00 → 1.5x.More in the Academy: Lesson debt, dividends and growth
1.2x
1
covered from 1.0x
You can see the dividend yield and shareholder yield (based on the price) with a free account.Sign up free
More depth
Calculation
Dividend per share: fiscal year 2020 0.96 USD → fiscal year 2025 0.52 USD = −11.4% per year
Free cash flow per share 0.65 USD ÷ dividend per share 0.52 USD = 1.2x
Years without a cut: in a row up to fiscal year 2025, dividend per share according to the SEC, adjusted for stock splits; only 1% less than the year before counts as a cut, also for variable dividends; a special dividend in the prior year does not. If the dividend per share falls while the total paid rises, the run ends as “unclear”. “At least” is shown only if our data ends earlier.
Shareholder yield: dividends paid plus share repurchases minus proceeds from new shares according to the cash flow statement of the last fiscal year, divided by today’s market value. Missing repurchases or new shares count as 0; without reported dividend or repurchase payments (among others for many stocks of the extended selection) there is no value. Describes the reported figures – not investment advice.
Valuation against its own historyWhere P/E, P/S or price/free cash flow stands today compared with the median of the company’s own last 5 fiscal years, in percent. Up to 10% deviation counts as “about at the median”. Describes only the position, not a judgement on an appropriate price.Example: P/E today 22, own 5-year median 27 → 22 ÷ 27 − 1 = −18.5%, so below the median.More in the Academy: Lesson cheaper or pricier than usual?
There is no comparison for the P/E: the last fiscal year ended with a loss.
With a free account you can see how far – and the same for P/S and price/free cash flow, with the calculation.Sign up free
Source: SEC filings and our daily candles
Dividends and share repurchases
How much the company returns to its shareholders – as dividends or by repurchasing its own shares – and whether free cash flow supports it.
Dividend per share
0.52USD · Fiscal year 2025
Dividend growth per year
3 y−23.2%5 y−11.4%10 y−8.5%
Payout ratio
of earnings–of free cash flow105%
To shareholders (5 years)
3.3B USD19% through repurchases
Share count over 5 years
−0.8%roughly unchanged
Dividend per share
The dividend per share fell in 5 years from 0.96 USD to 0.52 USD.
Dividend per shareUSD per sharePer share as filed with the SEC, including special dividends; obvious filing errors are hidden.
00.501.001.50
2016Fiscal year 2016: Dividend per share 0.51 USD
2017Fiscal year 2017: Dividend per share 0.61 USD
2018Fiscal year 2018: Dividend per share 0.73 USD
2019Fiscal year 2019: Dividend per share 0.85 USD
2020Fiscal year 2020: Dividend per share 0.96 USD
2021Fiscal year 2021: Dividend per share 1.09 USD
2022Fiscal year 2022: Dividend per share 1.15 USD
2023Fiscal year 2023: Dividend per share 1.16 USD
2024Fiscal year 2024: Dividend per share 1.04 USD
2025Fiscal year 2025: Dividend per share 0.52 USD
Payout ratios
Last reported for fiscal year 2023.
Payout ratio (earnings)Payout ratio (free cash flow)
0%50%100%150%
2016Fiscal year 2016: Payout ratio (earnings) 5.6% · Payout ratio (free cash flow) 28.7%
2017Fiscal year 2017: Payout ratio (earnings) 47.3% · Payout ratio (free cash flow) 26.2%
2018Fiscal year 2018: Payout ratio (earnings) 24.6% · Payout ratio (free cash flow) 26.6%
2019Fiscal year 2019: Payout ratio (earnings) 44.0% · Payout ratio (free cash flow) 30.0%
2020Fiscal year 2020: Payout ratio (earnings) 44.8% · Payout ratio (free cash flow) 40.8%
2021Fiscal year 2021: Payout ratio (earnings) 42.9% · Payout ratio (free cash flow) 35.8%
2022Fiscal year 2022: Payout ratio (earnings) not available · Payout ratio (free cash flow) 107.7%
2023Fiscal year 2023: Payout ratio (earnings) 22.1% · Payout ratio (free cash flow) 56.7%
2024Fiscal year 2024: Payout ratio (earnings) not available · Payout ratio (free cash flow) 103.0%
2025Fiscal year 2025: Payout ratio (earnings) not available · Payout ratio (free cash flow) 104.8%
What goes back to shareholders
Over 5 years, 3.3B USD went back to shareholders, 19% of it through share repurchases. That is 83% of the free cash flow of those years.
2016Fiscal year 2016: Dividends paid 268.0M USD · Share repurchases 292.0M USD · New shares issued (including employee plans) not available · Free cash flow 935.0M USD
2017Fiscal year 2017: Dividends paid 315.0M USD · Share repurchases 564.0M USD · New shares issued (including employee plans) not available · Free cash flow 1.2B USD
2018Fiscal year 2018: Dividends paid 376.0M USD · Share repurchases 2.5B USD · New shares issued (including employee plans) not available · Free cash flow 1.4B USD
2019Fiscal year 2019: Dividends paid 423.0M USD · Share repurchases 1.3B USD · New shares issued (including employee plans) not available · Free cash flow 1.4B USD
2020Fiscal year 2020: Dividends paid 473.0M USD · Share repurchases 500.0M USD · New shares issued (including employee plans) not available · Free cash flow 1.2B USD
2021Fiscal year 2021: Dividends paid 530.0M USD · Share repurchases 600.0M USD · New shares issued (including employee plans) not available · Free cash flow 1.5B USD
2022Fiscal year 2022: Dividends paid 573.0M USD · Share repurchases 32.0M USD · New shares issued (including employee plans) not available · Free cash flow 532.0M USD
2023Fiscal year 2023: Dividends paid 586.0M USD · Share repurchases 0.0 USD · New shares issued (including employee plans) not available · Free cash flow 1.0B USD
2024Fiscal year 2024: Dividends paid 590.0M USD · Share repurchases 0.0 USD · New shares issued (including employee plans) not available · Free cash flow 573.0M USD
2025Fiscal year 2025: Dividends paid 348.0M USD · Share repurchases not available · New shares issued (including employee plans) not available · Free cash flow 332.0M USD
Dividends paid, repurchases and new shares issued from the cash flow statement of annual reports filed with the SEC (as first reported). Describes the reported figures – not investment advice.
Valuation over time
Price-based valuation (P/E, P/S, price/free cash flow and dividend yield per fiscal year, compared with its own average) for signed-in users.Log in
Sector comparison
Baxter International next to 8 stocks of the sector Health Care we cover that are closest in revenue. Click a column header to sort the table.
Sector comparison BAX, sector Health Care; last row: sector median
Figures of the last fiscal year from SEC annual reports (peers as of Nov 22, 2026). Median across all companies of the sector we cover (from 5 stocks; several share classes of one company count once). Signed-in users also see P/E, P/S and dividend yield in the comparison. Describes the reported figures – not investment advice.
Key figures with traffic lights
Each light follows a simple, disclosed rule. The comparison is with the sector median Sector medianThe middle value of all companies in a sector: half are above it, half below. Unlike the average, single outliers hardly distort it.Example: Margins 4%, 8%, 10%, 12%, 60% → median 10%, average 18.8%.More in the Academy: Lesson putting the P/E in context of all 26 symbols in the Health Care sector on our list (current members of the S&P 500 and other lists).
Revenue growth
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light red: shrinking
−0.7%per year, last 5 years
Sector Health Care: median +8.5% (25 symbols)
What does this mean? Revenue: over 5 years it fell by 0.7% per year on average. The median company in the sector reached +8.5% per year.
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
Net income (total)
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light gray: not computable
–per year, last 5 years
Sector Health Care: median +5.5% (20 symbols)
per share: not computable (loss in the first or last year)
What does this mean? There was a loss in the first or last year. An annual growth rate cannot be calculated meaningfully then.
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
What does this mean? Of every 100 USD in revenue there was no profit but a loss of 8.51 USD. Five years ago the margin was 9.4%.
Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.
Debt / equity
Debt-to-equity ratioFinancial debt (loans, bonds) divided by equity. A high value amplifies good and bad years alike. The key figures bar in the chart only uses long-term financial debt.Example: Financial debt €300m, equity €500m → 0.6.More in the Academy: Lesson debt, dividends and growth
Light red: much higher
1.54latest balance sheet
Sector Health Care: median 0.66 (19 symbols)
What does this mean? For every 1 USD of equity there is 1.54 USD of financial debt – more than twice as much as the median company in the sector (0.66). More debt amplifies good and bad years alike.
Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.
Payout ratio
Payout ratioThe share of profit that a company pays out as a dividend. Above 100% it pays out more than it earns.Example: Dividend €1, earnings per share €2.50 → payout ratio 40%.More in the Academy: Lesson debt, dividends and growth
Light red: despite a loss
–Dividend / earnings per share
Sector Health Care: median 56% (16 symbols)
What does this mean? The company paid a dividend in the last fiscal year although there was a loss per share; it is paid from cash flow, from reserves or with new debt.
Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.
Profitable years
Profitable yearsHow many of the last fiscal years ended with a profit rather than a loss on the bottom line. The figure shows how consistently a company earns.Example: Profit in 9 of 10 years → one loss year.More in the Academy: Lesson revenue, profit and margin
Light red: 3 loss years
7 of 10fiscal years with a profit
What does this mean? In 7 of the last 10 fiscal years the bottom line showed a profit. 3 years ended with a loss.
Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).
Last fiscal year and 13F
Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
11.2B USD
Revenue vs. prior year
+5.7%
Net income (FY)
−957.0M USD
Net income vs. prior year
–
EPS (FY)
-1.87 USD
Superinvestors holding
1 of 26
Fiscal year to Dec 31, 2025 · 10-K filed Feb 12, 2026 · Balance sheet Dec 31, 2025 (filed Feb 12, 2026) · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term).Superinvestors: 26 tracked investors per 13F filing (as of quarter end, filed up to 45 days later); weight and change per investor in the card “Which superinvestors hold …?”.
All figures as a table
Fiscal years (amounts in USD, per share in USD)
Year
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
2025
Dec 31, 2025
11.2B
−957.0M
−8.5%
−1.87
0.52
–
2024
Dec 31, 2024
10.6B
−649.0M
−6.1%
−1.27
1.04
–
2023
Dec 31, 2023
14.8B
2.7B
17.9%
5.25
1.16
22%
2022
Dec 31, 2022
15.1B
−2.4B
−16.1%
−4.83
1.15
–
2021
Dec 31, 2021
12.8B
1.3B
10.0%
2.53
1.09
43%
2020
Dec 31, 2020
11.7B
1.1B
9.4%
2.13
0.96
45%
2019
Dec 31, 2019
11.4B
1.0B
8.8%
1.93
0.85
44%
2018
Dec 31, 2018
11.1B
1.6B
14.6%
2.97
0.73
25%
2017
Dec 31, 2017
10.6B
717.0M
6.8%
1.29
0.61
47%
2016
Dec 31, 2016
10.2B
5.0B
48.9%
9.01
0.51
6%
Quarters (amounts in USD, per share in USD)
Quarter
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
Q3/26
Sep 30, 2026
3.0B
294.0M
9.9%
0.57
0.01
2%
Q2/26
Jun 30, 2026
3.0B
126.0M
4.3%
0.24
0.01
4%
Q1/26
Mar 31, 2026
2.7B
−15.0M
−0.6%
−0.03
0.01
–
Q4/25*
Dec 31, 2025
3.0B
−1.1B
−37.9%
–
0.01
–
Q3/25
Sep 30, 2025
2.8B
−46.0M
−1.6%
−0.09
0.17
–
Q2/25
Jun 30, 2025
2.8B
91.0M
3.2%
0.18
0.17
94%
Q1/25
Mar 31, 2025
2.6B
126.0M
4.8%
0.25
0.17
68%
Q4/24
Dec 31, 2024
2.8B
−512.0M
−18.6%
−1.00
0.17
–
Q3/24
Sep 30, 2024
2.7B
140.0M
5.2%
0.27
0.29
107%
Q2/24
Jun 30, 2024
3.8B
−314.0M
−8.2%
−0.62
0.29
–
Q1/24
Mar 31, 2024
3.6B
37.0M
1.0%
0.07
0.29
414%
Q4/23
Dec 31, 2023
3.9B
245.0M
6.3%
0.48
0.29
60%
* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.
How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth over 5 years (otherwise 3 years). Quarters are labeled by the calendar quarter in which they end.
Information only – does not affect the other analysis methods, not investment advice.
Insiders
Insider transactionsExecutives, directors and major shareholders (over 10%) of US companies report their own transactions in their company’s stock to the SEC within two business days (Form 4). Purchases in the market count as more meaningful than sales (often taxes, estate planning).Example: Three executives acquire stock worth a total of 2 million USD within two weeks → “purchases by several insiders”.More in the Academy: Glossary
In the last 12 months, insiders of this stock have not acquired or disposed of shares on the market (SEC Form 4).
Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.
Which superinvestors hold Baxter International?
Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
Source: 13F filing with the US Securities and Exchange Commission, latest filing dated Nov 16, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.
Trend score –
We do not calculate a trend score for symbols in the extended universe.
Volatility and trend strength
ADX 14 (trend strength)–
Price change 60 days–
ATR ATR (Average True Range)The average range per trading day over the last 14 days. It makes distances comparable, whether a stock costs 10 or 1,000.Example: ATR 2.50 at a price of 100: 0.4 ATR is 1.00, i.e. 1%.More in the Academy: Lesson ATR and moving averages as price values only when logged in.